{
    "title": "J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12570867/J-Js-lung-cancer-therapy-combo-succeeds-late-stage-study.html",
    "date": "2023-09-28",
    "keywords": [
        "combination",
        "jampj",
        "therapy",
        "cancer",
        "tagrisso",
        "treatment",
        "bhanvi",
        "satija",
        "drug",
        "type",
        "non",
        "smallcell",
        "lung",
        "disease",
        "latestage",
        "study",
        "line",
        "analyst",
        "bar",
        "jampjs",
        "johnson",
        "time",
        "thursday",
        "nsclc",
        "mutation",
        "protein",
        "tumor",
        "cell",
        "growth",
        "analysis",
        "survival",
        "trend",
        "extent",
        "therapys",
        "trial",
        "society",
        "oncology",
        "conference",
        "opportunity",
        "liner",
        "vamil",
        "divan",
        "chemotherapy",
        "risk",
        "progression",
        "death",
        "profile",
        "use",
        "firstline",
        "spokesperson",
        "astrazeneca",
        "comparison",
        "tagrissochemo",
        "head",
        "newsletter",
        "health",
        "bengaluru",
        "editing",
        "kalluvila",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}